Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 388.90
+23.70 (6.49%)
Jan 16, 2026, 4:59 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.73 trillion as of January 16, 2026. Its market cap has decreased by -37.51% in one year.
Market Cap
1.73T
Enterprise Value
1.80T
Revenue
315.60B
Ranking
n/a
PE Ratio
16.67
Stock Price
388.90
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.73T, an increase of 3,656.49%. That is a compound annual growth rate of 13.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 1.62T | 12.28% |
| Dec 30, 2025 | 1.45T | -47.87% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 133.30B |
| Coloplast | 129.99B |
| ALK-Abelló | 49.28B |
| Demant | 49.25B |
| H. Lundbeck | 43.35B |
| Zealand Pharma | 28.69B |
| Ambu A/S | 24.00B |
| GN Store Nord | 16.98B |